An interventional study of lactase administration and placebo in Premature, Feeding Disorders and Lactase Deficiency, Congenital, sponsored by Alexandria University. Recruiting at 1 site in Egypt. Open to participants aged 3 Days to 1 Month. Per ClinicalTrials.gov, last updated 2026-01-16.
Sponsored by Alexandria University · Not applicable, Interventional, and Treatment
This study aims to study the effect of lactase enzyme in preventing feeding intolerance in preterm neonates in neonatal intensive care unit at Alexandria University Children's Hospital.
2,554 studies on the registry are indexed under Premature Birth; 498 are open to participants now.
This study's planned enrollment of 120 is above the median of 84 across 1,689 interventional studies indexed under Premature Birth.
Browse Premature Birth studies →Alexandria University is the lead sponsor of 569 studies on the registry; 125 are open to participants now.
Of its 12 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Counted across the registry records on this site, refreshed daily.
Inclusion criteria will be as follows:
Patients with any of the following will be excluded:
Drug: lactase administration
Other: placebo
1 drop for each 10 ml of formula milk for 14 days
10 ml milk without lactase
Feeding intolerance:
vomiting number per day aspirates in ml/day abdominal distension by measuring abdominal circumference before and after feeds
Time frame: first two weeks of life
Plan to share: Undecided
No publications or documents are linked to this record.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Alexandria University